2 Top Cannabis Stocks to Watch in August

After waves of bad news, these two cannabis companies, including Hexo Corp. (TSX:HEXO)(NYSE:HEXO), could have an interesting rest of the summer.

| More on:
Man holding magnifying glass over a document

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

It’s been a wild ride for cannabis investors so far this summer, and not like in the summer of 2018.

Whereas last year, there were the super highs from investors excited about the new industry, after several ups and downs, investors have become a lot more wary of where stocks are headed. With some cannabis stocks reporting profits and others severe losses, many are wondering where cannabis could be headed in the next month — especially as derivatives legalization comes ever closer.

Two stocks that investors now have a serious eye on are Canopy Growth (TSX:WEED)(NYSE:CGC) and Hexo (TSX:HEXO)(NYSE:HEXO), so let’s dig into where these two stocks could be headed for the remainder of the month.

Canopy

In case you hadn’t heard already, Canopy provided some incredibly terrible numbers to its investors last week. The company reported a loss of $1.28 billion, with Wall Street predicting somewhere around $107 million. This surprise to investors sent the company down about 15% after the news broke, and the stock is still headed in a downward spiral.

Yet some are already digging into the results and finding a silver lining. First of all, the major loss came from the company’s partnership with Constellation Brands. The same company that gave Canopy US$4 billion recently extinguished warrants worth $1.18 billion held by Constellation. This brings Canopy’s loss to about $105 million, which is actually less than what Wall Street predicted.

Of course, the rest of the earnings report wasn’t exactly positive, but it wasn’t terrible either. In fact, Canopy had a record harvest, producing more than any other cannabis company. The company will hopefully cut back on spending, and in the meantime focus on the potential to become a derivatives powerhouse. While Canopy still has about $3.1 billion of cash on hand, the company will really have to start proving it can bring in cash if it wants to bring back investors. Management remains positive that it will reach $1 billion in revenue by the end of 2020, with profit in the next three to five years.

So, why watch it in August? As the dust settles, I believe investors will realize quickly this stock is a bargain. So, it might be time to buy it up before the next wave hits.

Hexo

Another company worth keeping an eye on is Hexo — a cannabis company that could soon make some serious announcements ahead of the derivatives market introduction to Canada. The company recently announced its dried flower cannabis products are now available to Ontario customers, which should give its earnings a boost from Canada’s most populated province.

But what has analysts really excited is the company’s partnership with Molson Coors and Newstrike Brands, as the company could come out as a leader in the consumable and vape industries — two areas that could prove incredibly lucrative.

However, Hexo also suffered from poor results recently, as the company only reported a slight increase in revenue. While production doubled, the stock still suffered a loss of $1.9 million.

Why watch it in August? Hexo should deliver its next earnings report on Sept. 12, 2019. Analysts and investors alike will be looking out for some good news, good revenues, and hopefully some good announcements ahead of edibles legalization.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Canopy Growth.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »